Global network expansion with two more new partners for Chile and Ukraine.
Earlier this month, Paxman announced Sistemplus SA as its exclusive distribution partner for Chile, and Medinova LLC as its global distribution partner for Paxman equipment in Ukraine.
With headquarters in the Chilean capital Santiago, Sistemplus SA is well placed to introduce scalp cooling in the Chilean market with its existing strong relationships with key reference physicians, private and public hospitals, as well as oncology groups.
Despite being a relatively small country, Chile has a population of over 19 million and has a very high Human Development Index (HDI) which is ranked as 43 out of 189 countries.
Breast cancer is the most common cancer from both an incidence and mortality point of view, with a new diagnosis of breast cancer every three hours and three women dying daily. The highest incidence of cancer in men is prostate cancer and stomach cancer is the most common cause of death in men. In 2018, 5,393 breast cancer diagnoses were made in Chile.
In 2018, the country launched its ten-year national cancer plan with an expected investment of $ 25 million in equipment and infrastructure across the country, to include 11 new cancer centers. In 2022, the Ministry of Health will distribute 130 oncologists and, more importantly, the launch of the national cancer registry.
Based in Kiev, Medinova LLC is ready to launch the Paxman Scalp Cooling System (PSCS) for oncology centers throughout Ukraine and add Paxman to its portfolio of world-leading medical technology products. Medinova’s strong reputation puts them in a good position for the introduction of scalp cooling to their already established customer base across Ukraine.
With a population of 43,514,481, cancer is the second leading cause of death in the country and accounts for 12% of the total figure. There are 326 new cases of cancer per 100,000 per year. The cancer prevalence is 1.7%. Breast cancer is the most common cancer in women, accounting for 82,451 cases in 2020.
Ukraine has a well-established network of private, specialized oncology clinics, and while the health care in the country is part of a guaranteed, universal free healthcare system, in practice most people themselves contribute to the cost of treatment. The transformation is underway with a transition to a public health care system based on insurance-based medicines.